Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread

Lars Hangartner, Raphaël M. Zellweger, Mattia Giobbi, Jacqueline Weber, Bruno Eschli, Kathy D. McCoy, Nicola Harris, Mike Recher, Rolf M. Zinkernagel, Hans Hengartner

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Abstract

The biological relevance of nonneutralizing antibodies elicited early after infection with noncytopathic persistence-prone viruses is unclear. We demonstrate that cytotoxic T lymphocyte-deficient TgH(KL25) mice, which are transgenic for the heavy chain of the lymphocytic choriomeningitis virus (LCMV)-neutralizing monoclonal antibody KL25, mount a focused neutralizing antibody response following LCMV infection, and that this results in the emergence of neutralization escape virus variants. Further investigation revealed that some of the escape variants that arose early after infection could still bind to the selecting antibody. In contrast, no antibody binding could be detected for late isolates, indicating that binding, but nonneutralizing, antibodies exerted a selective pressure on the virus. Infection of naive TgH(KL25) mice with distinct escape viruses differing in their antibody-binding properties revealed that nonneutralizing antibodies accelerated clearance of antibody-binding virus variants in a partly complement-dependent manner. Virus variants that did not bind antibodies were not affected. We therefore conclude that nonneutralizing antibodies binding to the same antigenic site as neutralizing antibodies are biologically relevant by limiting early viral spread. JEM

Original languageEnglish
Pages (from-to)2033-2042
Number of pages10
JournalJournal of Experimental Medicine
Volume203
Issue number8
DOIs
Publication statusPublished - 7 Aug 2006
Externally publishedYes

Cite this